𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes

✍ Scribed by Robert W. Yeh; Suzanne J. Baron; Joanne L. Healy; Eugene Pomerantsev; Iris A. McNulty; Ignacio Cruz-Gonzalez; Ik-Kyung Jang

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
69 KB
Volume
74
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Report of successful use of argatroban a
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome
✍ Lewis, Bruce E. ;Iaffaldano, Robert ;McKiernan, Thomas L. ;Rao, Luxman ;Donkin, πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 2 views

Heparin-induced thrombocytopenia and thrombosis syndrome (HITTS) is a severe complication of heparin caused by an antibody response to the heparin-platelet factor 4 complex which results in severe thrombosis. Heparin rechallenge in HllTS patients carries a high risk of inducing thrombosis. Antithrom

Treatment with tumor necrosis factor inh
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
✍ Lotta Ljung; Julia F. Simard; Lennart Jacobsson; Solbritt RantapÀÀ-Dahlqvist; Jo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 3 views

## Abstract ## Objective Rheumatoid arthritis (RA) is associated with an increased risk of ischemic heart disease, in both early and established RA. Data on the risk of ischemic heart disease in relation to therapy with tumor necrosis factor (TNF) antagonists (anti‐TNF) are conflicting in patients